Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Line Development Market

Cell Line Development Market Share

  • Report ID: GMI429
  • Published Date: Mar 2022
  • Report Format: PDF
 Download Free Sample

Cell Line Development Market Share

Some of the key players operating in the cell line development industry are

  • Advanced Instruments, LLC.
  • AGC Biologics
  • Catalent
  • Corning Inc.
  • Cyagen
  • Cytiva
  • Eurofins
  • FUJIFILM Diosynth Biotechnologies
  • GenScript Biotech Corporation
  • Horizon Discovery
  • Imgenex
  • Lonza
  • NAEJA RGM Pharmaceuticals
  • Novartis
  • Premas Biotech
  • Probiogen
  • PromoCell
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Sartorius AG
  • Selexis SA
  • Vista Biologics
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Vista Biologicals
  • WuXi AppTec 

These market players are implementing various growth strategies, partnerships, launches, mergers, and acquisitions to enhance product capabilities to sustain market competition in the cell line development industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cell line development market is slated to surpass USD 11.6 billion by 2028 and could grow at a CAGR of about 10.1% from 2022 to 2028 driven by growing vaccine production and constant technological developments.

In 2021, the reagents and media segment captured around 53% of the overall market share and will grow as the product contains supplements and sera that support cell survival, biological function, and proliferation.

The overall market revenue from recombinant cell lines could grow at a CAGR of more than 9.5% over 2022-2028 driven by increasing investment in R&D activities to develop new products and constant technological advancements.

Cell line development market share from bioproduction application was recorded at around USD 2.7 billion in 2021 and will grow owing to soaring expenditure on R&D to produce various biological substances like vaccines, antibiotics, and more.

North America held more than 34% of the global cell line development market share in 2021 owing to novel drug discoveries further encouraging the adoption of different and unique bioproduction procedures.

Cell Line Development Market Scope

  • Cell Line Development Market Size
  • Cell Line Development Market Trends
  • Cell Line Development Market Analysis
  • Cell Line Development Market Share

    • Buy Now

    Immediate Delivery Available

    Premium Report Details

    • Base Year: 2021
    • Companies covered: 26
    • Tables & Figures: 351
    • Countries covered: 17
    • Pages: 238
     Download Free Sample
    ×
    Get a free sample of Cell Line Development Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.